Abstract A collision tumor is a neoplastic lesion comprised of two or more distinct cell populations that maintain distinct borders. Collision tumors, which are rare but well‐documented, can be composed of two benign tumors, a benign and malignant tumor, and two malignant tumors. Although case reports and reviews on specific types of collision tumors exist, a cohesive source discussing these tumors is lacking. We critically reviewed the literature by analyzing case reports and retrospective studies...
Thu Aug 27, 2020 14:31
Abstract Beautiful lips are responsible for facial attractiveness and a youthful appearance. During aging process, lips become thinner and the red lips borders get poor defined. Downturn of the corners of the mouth suggest negative emotions. Lip surgery and underlying pathology may result in asymmetries and lip incontinence. Minor invasive procedures with hyaluronic acid fillers and botulinum toxin A are versatile tools to improve appearance of the lips, restore function and improve psycho‐social...
Thu Aug 27, 2020 14:30
Abstract Low‐Level Laser Therapy (LLLT) has been investigated for the treatment of various dermatological disorders. Here, we investigate the efficacy of LLLT for the treatment of cutaneous leishmaniasis (CL). This study comprised of 53 patients (total 123 lesions) with a confirmed diagnosis of CL via positive smear of LD‐bodies. The CL lesions were classified in Grade I (i.e., papule of size ≤ 1 cm) to Grade V (i.e., vesicle formation, ulceration & superadded infection of size > 4 cm). All...
Thu Aug 27, 2020 14:24
Abstract A subset of leprosy patients have clinical and histopathological activity in the form of persistent plaques and granulomas after completion of multidrug therapy (MDT) which can have significant impact on their quality of life. In the absence of clear guidelines regarding management of such patients, majority of the times they are treated either as late reversal reaction with corticosteroids or no active treatment is offered. We observed 11 patients of leprosy with persistent plaques after...
Thu Aug 27, 2020 14:24
Abstract Oral minoxidil (OM) has been reported to be effective for androgenetic alopecia (AGA). In this retrospective study, we share our experience of using OM for > 24 weeks in 12 patients with female AGA (Ludwig scale I‐3‐III). Twelve women (aged 18‐66 years; mean age 36.66±18.79 years) with AGA (Ludwing scale I‐3‐III) were recruited. The starting dose of minoxidil was 0.50 mg daily, at three months, the dose was increased to 1.50‐2 mg daily. Efficacy outcome measures were evaluated at baseline...
Wed Aug 26, 2020 20:52
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου